Next-generation Semax analogue with adamantane modification — superior BBB penetration, enhanced enzymatic stability, and stronger BDNF/TrkB activation than standard Semax.
The adamantane modification on the N-terminus dramatically increases lipophilicity and enzymatic stability compared to Semax. This allows greater penetration of the blood-brain barrier and longer active duration. Once in the CNS, Adamax upregulates BDNF and NGF expression, activates TrkB receptors, and potentiates the HGF/c-Met pathway — producing stronger and more sustained nootropic effects than parent Semax.
Adamax (Ac-MEHFPGP-AG-NH2) is a designer analogue of Semax incorporating the N-terminal and C-terminal modifications found in Peptide P21. The adamantane group confers significantly greater resistance to enzymatic degradation and increased lipophilicity — meaning more of the peptide reaches the brain intact compared to standard Semax.
Research suggests Adamax may improve endurance 2–3× more than other Semax analogues. Often compared to N-Acetyl Semax Amidate but considered more potent due to the adamantane modification. Often stacked with Selank for a combined nootropic + anxiolytic protocol.